{"DataElement":{"publicId":"3261503","version":"1","preferredName":"Estrogen Receptor Percentage Immunohistochemistry Stain Minimum Intensity Score","preferredDefinition":"The score assigned to the minimum Estrogen Receptor Immunohistochemistry stain intensity used to determine a positive finding.","longName":"2419208v1.0:3261487v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2419208","version":"1","preferredName":"Estrogen Receptor Percentage Intensity Stain Description","preferredDefinition":"information related to the description or status of estrogen receptors, cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain and a C-terminal steroid-binding domain, based on percentage and intensity of stained cells.","longName":"ER_PER_INT_STA_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2419205","version":"1","preferredName":"ER","preferredDefinition":"Widely expressed human Estrogen Receptors (NR3 Family) are ligand-activated nuclear hormone receptor transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","longName":"C17069","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Family","conceptCode":"C17069","definition":"Widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0307659E-EFAD-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"ONEDATA","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2419206","version":"1","preferredName":"Percentage Intensity Stain Description ","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:The degree or magnitude of strength, energy, or feeling.:a dye or other coloring material that is used in microscopy to make structures visible.:Description; a statement that represents something in words.","longName":"C25613:C25539:C0038128:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Intensity","conceptCode":"C25539","definition":"The degree or magnitude of strength, energy, or feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stain","conceptCode":"C0038128","definition":"a dye or other coloring material that is used in microscopy to make structures visible.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0307659E-EFB3-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"ONEDATA","dateModified":"2005-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0307659E-EFB4-15EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3261487","version":"1","preferredName":"Minimum Immunohistochemistry Staining Method Intensity Score","preferredDefinition":"The smallest possible quantity._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._The degree or magnitude of strength, energy, or feeling._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"3261487v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3261486","version":"1","preferredName":"Minimum Immunohistochemistry Staining Method Intensity Score","preferredDefinition":"The smallest possible quantity.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:The degree or magnitude of strength, energy, or feeling.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25570:C23020:C25539:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimum","conceptCode":"C25570","definition":"The smallest possible quantity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intensity","conceptCode":"C25539","definition":"The degree or magnitude of strength, energy, or feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2D3571-02A0-A9F2-E040-BB89AD431895","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"ONEDATA","dateModified":"2011-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2D3571-02B1-A9F2-E040-BB89AD431895","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"COOPERM","dateModified":"2011-08-16","changeDescription":"Released per approval by T.Lichtenberg. mc 8/16/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5589063","version":"1","longName":"CDDP/CTSP (Cancer Driver Discovery Program/Clinical Trial Sequencing Project)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"5589068","version":"1","longName":"CDDP/CTSP","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If ER IHC intensity is consid","type":"Preferred Question Text","description":"If ER IHC intensity is considered, what is the cut off for positive?","url":null,"context":"NCIP"},{"name":"CTSP Question","type":"Alternate Question Text","description":"What was the cutoff percentage used to determine positivity for ER status?","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA2EC7A9-7EE2-E444-E040-BB89AD437977","latestVersionIndicator":"Yes","beginDate":"2011-08-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-10","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per TCGA approval by T.Lichtenberg. mc 8/16/11 Reclassified to CDDP/CTSP - smt 12/21/16.3/24/2017 added alt question text for CTSP task, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}